Aspen Pharmacare EPS - Earnings per Share 2017-2023 | APNHY
Aspen Pharmacare annual and quarterly earnings per share history from 2017 to 2023. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Aspen Pharmacare EPS for the quarter ending June 30, 2023 was $0.00, a NAN% increase year-over-year.
- Aspen Pharmacare EPS for the twelve months ending June 30, 2023 was $0.00, a NAN% increase year-over-year.
- Aspen Pharmacare 2023 annual EPS was $0.66, a 29.59% decline from 2022.
- Aspen Pharmacare 2022 annual EPS was $0.94, a 37.26% increase from 2021.
- Aspen Pharmacare 2021 annual EPS was $0.69, a 4.41% increase from 2020.
| Aspen Pharmacare Annual EPS |
| 2023 |
$0.66 |
| 2022 |
$0.94 |
| 2021 |
$0.69 |
| 2020 |
$0.66 |
| 2019 |
$1.00 |
| 2018 |
$1.03 |
| 2017 |
$0.83 |
| 2016 |
$0.66 |
| 2015 |
$0.00 |
| Aspen Pharmacare Quarterly EPS |
| 2023-06-30 |
$0.00 |
| 2022-12-31 |
$0.00 |
| 2022-06-30 |
$0.00 |
| 2021-12-31 |
$0.00 |
| 2021-06-30 |
$0.00 |
| 2020-12-31 |
$0.00 |
| 2020-06-30 |
$0.00 |
| 2019-06-30 |
$0.00 |
| 2018-12-31 |
$0.00 |
| 2018-06-30 |
$0.00 |
| 2017-12-31 |
$0.00 |
| 2017-06-30 |
$0.00 |
| 2016-12-31 |
$0.00 |
| 2016-06-30 |
$0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$5.038B |
$2.296B |
|
Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
|
